Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28440
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Harper, David G. | - |
dc.contributor.author | Ravichandran, Caitlin | - |
dc.contributor.author | Iosifescu, Dan Vlad | - |
dc.contributor.author | Renshaw, Perry Franklin | - |
dc.contributor.author | Forester, Brent P. | - |
dc.date.accessioned | 2022-09-02T11:38:48Z | - |
dc.date.available | 2022-09-02T11:38:48Z | - |
dc.date.issued | 2014-05 | - |
dc.identifier.citation | Harper, D. G. vd. (2014). "Tissue-specific differences in brain phosphodiesters in late-life major depression". American Journal of Geriatric Psychiatry, 22(5), 499-509. | en_US |
dc.identifier.issn | 1064-7481 | - |
dc.identifier.issn | 1545-7214 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jagp.2012.08.005 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/S1064748112000322 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28440 | - |
dc.description.abstract | Objective: Late-life depression has been hypothesized to have a neurodegenerative component that leads to impaired executive function and increases in subcortical white matter hyperintensities. Phosphorus magnetic resonance spectroscopy (MRS) can quantify several important phosphorus metabolites in the brain, particularly the anabolic precursors and catabolic metabolites of the constituents of cell membranes, which could be altered by neurodegenerative activity. Methods: Ten patients with late-life major depression who were medication free at time of study and 11 aged normal comparison subjects were studied using P-31 MRS three-dimensional chemical shift imaging at 4 Tesla. Phosphatidylcholine and phosphatidylethanolamine comprise 90% of cell membranes in brain but cannot be quantified precisely with 31P MRS. We measured phosphocholine and phosphoethanolamine, which are anabolic precursors, as well as glycerophosphocholine and glycerophosphoethanolamine, which are catabolic metabolites of phosphatidylcholine and phosphatidylethanolamine. Results: In accordance with our hypotheses, glycerophosphoethanolamine was elevated in white matter of depressed subjects, suggesting enhanced breakdown of cell membranes in these subjects. Glycerophosphocholine did not show any significant difference between comparison and depressed subjects but both showed an enhancement in white matter compared with gray matter. Contrary to our hypotheses, neither phosphocholine nor phosphoethanolamine showed evidence for reduction in late-life depression. Conclusion: These findings support the hypothesis that neurodegenerative processes occur in white matter in patients with late-life depression more than in the normal elderly population. | en_US |
dc.description.sponsorship | Rogers' Family Foundation | en_US |
dc.description.sponsorship | NARSAD | en_US |
dc.description.sponsorship | Pfizer (K23 MH07728) (R01 MH058681) (R01 DA015116) (R01 AG20654) | en_US |
dc.description.sponsorship | Harvard Catalyst | en_US |
dc.description.sponsorship | Johnson & Johnson Johnson & Johnson USA Janssen Biotech Inc | en_US |
dc.description.sponsorship | Eli Lilly | en_US |
dc.description.sponsorship | Organon | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Aging (NIA) | en_US |
dc.description.sponsorship | GlaxoSmithKline | en_US |
dc.description.sponsorship | Roche Holding | en_US |
dc.description.sponsorship | Aspect Medical Systems | en_US |
dc.description.sponsorship | Forest Laboratories | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of Mental Health (NIMH) (R01MH058681) (K23MH077287) | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Aging (NIA) (R01AG020654) | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute on Drug Abuse (NIDA) European Commission (K24DA015116) (K05DA031247) | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | MRSI | en_US |
dc.subject | P-31 MRS | en_US |
dc.subject | Elderly | en_US |
dc.subject | Aging | en_US |
dc.subject | Membranes | en_US |
dc.subject | White-matter lesions | en_US |
dc.subject | Phosphatidylcholine metabolism | en_US |
dc.subject | Executive dysfunction | en_US |
dc.subject | Cultured-cells | en_US |
dc.subject | Frontal-lob | en_US |
dc.subject | 4 Tesla | en_US |
dc.subject | Phosphatidylethanolamine | en_US |
dc.subject | Biosynthesis | en_US |
dc.subject | Disease | en_US |
dc.subject | Burden | en_US |
dc.subject | Geriatrics & gerontology | en_US |
dc.subject | Psychiatry | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 and over | en_US |
dc.subject.mesh | Aging | en_US |
dc.subject.mesh | Brain | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Depressive disorder, major | en_US |
dc.subject.mesh | Ethanolamines | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Glycerylphosphorylcholine | en_US |
dc.subject.mesh | Gray matter | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Magnetic resonance spectroscopy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Organophosphorus compounds | en_US |
dc.subject.mesh | Phosphatidylethanolamines | en_US |
dc.subject.mesh | Phosphorylcholine | en_US |
dc.subject.mesh | White matter | en_US |
dc.title | Tissue-specific differences in brain phosphodiesters in late-life major depression | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000336087200010 | tr_TR |
dc.identifier.scopus | 2-s2.0-84901392294 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Ruh Sağlığı ve Hastalıkları Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 499 | tr_TR |
dc.identifier.endpage | 509 | tr_TR |
dc.identifier.volume | 22 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | American Journal of Geriatric Psychiatry | en_US |
dc.contributor.buuauthor | Sivrioğlu, Yusuf | - |
dc.contributor.buuauthor | Jensen, J. Eric | - |
dc.contributor.buuauthor | Silveri, Marisa M. | - |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 23567437 | tr_TR |
dc.subject.wos | Geriatrics & gerontology | en_US |
dc.subject.wos | Gerontology | en_US |
dc.subject.wos | Psychiatry | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | SSCI | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 14062563200 | tr_TR |
dc.contributor.scopusid | 7404521823 | tr_TR |
dc.contributor.scopusid | 7005924854 | tr_TR |
dc.subject.scopus | Depression; Cognitive Dysfunction; Dementia | en_US |
dc.subject.emtree | Glycerophosphoethanolamine | en_US |
dc.subject.emtree | Glycerophosphorylcholine | en_US |
dc.subject.emtree | Phosphatidylcholine | en_US |
dc.subject.emtree | Phosphatidylethanolamine | en_US |
dc.subject.emtree | Phosphodiesterase | en_US |
dc.subject.emtree | Phosphoethanolamine | en_US |
dc.subject.emtree | Phosphorylcholine | en_US |
dc.subject.emtree | Ethanolamine derivative | en_US |
dc.subject.emtree | Glycerophosphoethanolamine | en_US |
dc.subject.emtree | Glycerophosphorylcholine | en_US |
dc.subject.emtree | Organophosphorus compound | en_US |
dc.subject.emtree | Phosphatidylethanolamine | en_US |
dc.subject.emtree | Phosphoethanolamine | en_US |
dc.subject.emtree | Phosphorylcholine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cell membrane | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Gray matter | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Image enhancement | en_US |
dc.subject.emtree | Late life depression | en_US |
dc.subject.emtree | Major depression | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Phospholipid membrane | en_US |
dc.subject.emtree | Phospholipid metabolism | en_US |
dc.subject.emtree | Phosphorus nuclear magnetic resonance | en_US |
dc.subject.emtree | Protein degradation | en_US |
dc.subject.emtree | Protein synthesis | en_US |
dc.subject.emtree | Proton nuclear magnetic resonance | en_US |
dc.subject.emtree | Quantitative analysis | en_US |
dc.subject.emtree | Three dimensional imaging | en_US |
dc.subject.emtree | Tissue specificity | en_US |
dc.subject.emtree | White matter | en_US |
dc.subject.emtree | Aging | en_US |
dc.subject.emtree | Brain | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Major depression | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Nuclear magnetic resonance spectroscopy | en_US |
dc.subject.emtree | Psychology | en_US |
dc.subject.emtree | Very elderly | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.